⌘K
Loading ticker…
The Chemours Company · Healthcare · Chemicals
As of 2026-06-26, The Chemours Company (CC) has a 3-month relative strength percentile of 33 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.5%, relative volume 2.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
33 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
CC is held by 8 ETFs as of Mar 2026. Top owner: IJR at 0.22% weight, $199M notional. Top 3 carry $387M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.22% | $199M |
| VTIVanguard Total Stock Market ETF | 0.01% | $106M |
| IWMiShares Russell 2000 ETF | 0.11% | $81M |
| VBVanguard Small Cap ETF | 0.05% | $76M |
| VBRVanguard Small Cap Value ETF | 0.08% | $49M |
| VXFVanguard Extended Market ETF | 0.05% | $37M |
| IWOiShares Russell 2000 Growth ETF | 0.22% | $27M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $4M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CC Jan avg: 13.50% median: 15.60% win: 75% σ: 13.35% n: 4 2022-04-12 → 2026-05-29 | CC Feb avg: -10.12% median: -13.67% win: 25% σ: 24.23% n: 4 2022-04-12 → 2026-05-29 | CC Mar avg: 8.09% median: 5.64% win: 50% σ: 22.63% n: 4 2022-04-12 → 2026-05-29 | CC Apr avg: 2.95% median: 1.87% win: 60% σ: 11.65% n: 5 2022-04-12 → 2026-05-29 | CC May avg: -4.35% median: -8.88% win: 20% σ: 20.00% n: 5 2022-04-12 → 2026-05-29 | CC Jun avg: 4.38% median: 1.98% win: 50% σ: 28.14% n: 4 2022-04-12 → 2026-05-29 (current) | CC Jul avg: 5.78% median: 5.86% win: 100% σ: 4.57% n: 4 2022-04-12 → 2026-05-29 | CC Aug avg: -1.06% median: -6.62% win: 25% σ: 20.70% n: 4 2022-04-12 → 2026-05-29 | CC Sep avg: -9.27% median: -7.35% win: 50% σ: 15.47% n: 4 2022-04-12 → 2026-05-29 | CC Oct avg: -6.00% median: -12.34% win: 25% σ: 14.90% n: 4 2022-04-12 → 2026-05-29 | CC Nov avg: 9.36% median: 11.11% win: 75% σ: 10.31% n: 4 2022-04-12 → 2026-05-29 | CC Dec avg: -4.12% median: -4.60% win: 25% σ: 15.44% n: 4 2022-04-12 → 2026-05-29 |